All Stories

  1. Targeting cell cycle and hormone receptor pathways in cancer

    Article • Oncogene, May 2013, Springer Science + Business Media

    Dr Clay Comstock

  2. Cyclin D1 Is a Selective Modifier of Androgen-dependent Signaling and Androgen Receptor Function

    Article • Journal of Biological Chemistry, January 2011, American Society for Biochemistry & Molecular Biology (ASBMB)

    Jason Karch, Dr Clay Comstock

  3. The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression

    Article • Journal of Clinical Investigation, December 2010, American Society for Clinical Investigation

    Dr Clay Comstock

  4. Identification of ASF/SF2 as a Critical, Allele-Specific Effector of the Cyclin D1b Oncogene

    Article • Cancer Research, May 2010, American Association for Cancer Research (AACR)

    Dr Clay Comstock

  5. Alternative Splicing of the Cyclin D1 Proto-Oncogene Is Regulated by the RNA-Binding Protein Sam68

    Article • Cancer Research, December 2009, American Association for Cancer Research (AACR)

    Dr Clay Comstock

  6. Functional Specificities of Brm and Brg-1 Swi/Snf ATPases in the Feedback Regulation of Hepatic Bile Acid Biosynthesis

    Article • Molecular and Cellular Biology, October 2009, ASM Journals

    Dr Clay Comstock

  7. Cyclin D1 Splice Variants: Polymorphism, Risk, and Isoform-Specific Regulation in Prostate Cancer

    Article • Clinical Cancer Research, August 2009, American Association for Cancer Research (AACR)

    Jason Karch, Dr Clay Comstock

  8. Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome

    Article • Oncogene, March 2009, Nature

    Dr Clay Comstock

  9. Targeting the BAF57 SWI/SNF Subunit in Prostate Cancer: A Novel Platform to Control Androgen Receptor Activity

    Article • Cancer Research, June 2008, American Association for Cancer Research (AACR)

    Dr Clay Comstock

  10. Cyclin D3 action in androgen receptor regulation and prostate cancer

    Article • Oncogene, December 2007, Nature

    Dr Clay Comstock

  11. Unique Bisphenol A Transcriptome in Prostate Cancer: Novel Effects on ERβ Expression That Correspond to Androgen Receptor Mutation Status

    Article • Environmental Health Perspectives, August 2007, Environmental Health Perspectives

    Dr Clay Comstock

  12. Retinoblastoma Tumor Suppressor Status Is a Critical Determinant of Therapeutic Response in Prostate Cancer Cells

    Article • Cancer Research, July 2007, American Association for Cancer Research (AACR)

    Dr Clay Comstock

  13. The Complex Role of AR Signaling After Cytotoxic Insult: Implications for Cell Cycle Based Chemotherapeutics

    Article • Cell Cycle, June 2007, Taylor & Francis

    Dr Clay Comstock

  14. Impact of differential cyclin D1 expression and localisation in prostate cancer

    Article • British Journal of Cancer, March 2007, Nature

    Dr Clay Comstock

  15. Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer

    Article • Molecular Cancer Therapeutics, December 2006, American Association for Cancer Research (AACR)

    Dr Clay Comstock

  16. LS14: A Novel Human Adipocyte Cell Line that Produces Prolactin

    Article • Endocrinology, January 2006, Endocrine Society

    Dr Clay Comstock

  17. Cyclic Nucleotide Specificity and Cross-Activation of Cyclic Nucleotide Receptors

    Article • January 2003, Elsevier

    Dr Clay Comstock

  18. Gene Profiling Analysis of Androgen Receptor Mediated Function

    Article • Springer Science + Business Media

    Dr Clay Comstock

  19. Androgen-mediated Control of the Cyclin D1-RB Axis: Implications for Prostate Cancer

    Article • Springer Science + Business Media

    Dr Clay Comstock